The Nifty 50 fell 205.50 points (0.84%) to close at 24,173.10, while the Sensex dropped 852.49 points (1.09%) to settle at 77,664.
Nifty MidCap fell 0.41%
Nifty SmallCap dropped 0.67%
Impact On The Stock Market
Sector-wise, the impact was clearly visible.
The Nifty Auto, PSU Bank, and Realty sectors declined the most, showing pressure in cyclical and interest-rate-sensitive stocks. These sectors are typically more vulnerable when inflation risks rise due to higher oil prices.
On the other hand, the Nifty Pharma sector emerged as the top gainer, acting as a defensive play amid uncertainty.
| Sector/Index | Performance |
| IT & BPM sector | -1.22% |
| Healthcare sector | 2.11% |
| Oil & Gas sector | -0.76% |
| Real estate sector | -1.83% |
| PSU Bank in India | -2.19% |
Top gainers today
| Company | Share Price (in ₹) | Change % |
| Dr Reddys Labs | 1,331.00 | 9.37 |
| Cipla | 1,305.90 | 5.63 |
| Jio Financial | 248.66 | 4.26 |
| Adani Enterprise | 2,300.00 | 1.73 |
| Apollo Hospital | 7,781.00 | 1.55 |
Top losers today
| Company | Share Price (in ₹) | Change % |
| Trent | 4,251.40 | -4.13 |
| Shriram Finance | 1,009.30 | -3.37 |
| M&M | 3,047.70 | -3.24 |
| SBI Life Insurance | 1,828.10 | -3.01 |
| Tech Mahindra | 1,421.50 | -2.81 |
Market aftermath: Impact on stocks
Infosys: Strong results, but cautious outlook
Infosys delivered a strong Q4 performance, but the market reaction remained muted due to a cautious outlook.
The company reported a 27.8% quarter-on-quarter jump in net profit to ₹8,501 crore, beating expectations. Revenue came in at ₹46,402 crore, with a modest 2% sequential growth.
Margins improved significantly:
- EBIT rose 16.6% to ₹9,743 crore
- EBIT margin expanded to 21% from 18.4%
The company also announced a final dividend of ₹25 per share.
However, the bigger concern was guidance. Infosys expects FY27 revenue growth between 1.5% and 3.5%, signalling a slowdown in demand.
This reflects broader challenges in the IT sector, including weak global demand and reduced discretionary spending by clients.
Pharma stocks: Defensive rally continues
Pharma stocks stood out as one of the few bright spots in today’s market.
The Nifty Pharma index rose 2.5%, supported by strong growth prospects and favourable currency movements.
Key gainers included:
- Dr Reddy’s Laboratories (up ~10%)
- Piramal Pharma (up 6.5%)
- Cipla (up 5.5%)
The sector is benefiting from:
- Strong export demand
- Rupee depreciation boosting earnings
- Positive outlook for global pharmaceutical markets
Brokerages expect the Indian pharma market to continue growing at over 10% annually, making it an attractive defensive play in uncertain times.
Banking stocks: Foreign outflows weigh heavily
Banking stocks came under pressure, with the Bank Nifty falling 1.4%, extending its decline for the second day.
The key reason? Persistent foreign outflows.
- Foreign investors have sold $4.3 billion worth of Indian equities in April
- Total outflows in 2026 have reached $18.5 billion
Both FIIs and DIIs were net sellers in the recent session, which is relatively rare and signals profit booking.
PSU banks led the losses:
- Union Bank of India fell 6%
- Bank of Baroda dropped 2.62%
- Canara Bank declined 2.6%
Rising crude prices have also weakened the rupee, which fell past ₹94 per dollar, adding further pressure on banking stocks.
Higher oil prices could lead to:
- Increased borrowing costs
- Higher bond yields
- Reduced treasury gains for banks
This combination is weighing heavily on the sector.
Crude oil
Crude oil prices surged again, becoming the biggest concern for global markets.
- Brent crude crossed $103.40, rising 1.46%
- WTI crude climbed to $94.53, up 1.69%
- On MCX, crude prices rose over 2%
The spike is driven by escalating tensions in the Strait of Hormuz, where Iran has seized vessels, raising fears of prolonged supply disruptions.
Key concerns include:
- Disruptions to global shipping routes
- Reduced oil supply
- Rising fuel costs globally
Experts warn that the market is now repricing oil expectations, with Brent moving back above $100 per barrel.
There are also signs of demand destruction, especially in aviation, where rising jet fuel prices are leading to flight cancellations.
At the same time:
- The US is exporting record levels of oil (12.88 million barrels/day)
- Global buyers are shifting to alternative sources
- Supply tightness is increasing despite these efforts
The longer the disruption continues, the more pressure it will put on global economies—including India.
Conclusion
Today’s market fall is a reminder of how quickly sentiment can shift.
Just a few days ago, markets were rallying on hopes of peace. Now, rising tensions and oil prices are pulling indices lower.
The biggest risk right now is crude oil. If prices continue to rise, it could trigger:
- Higher inflation
- Slower economic growth
- Increased market volatility
At the same time, sectoral divergence is becoming clearer. While pharma stocks are gaining, banking and cyclical sectors are under pressure.
For investors, this is a time to stay cautious and selective. Focus on sectors that can withstand global shocks and avoid chasing momentum blindly.
